Health + Behavior

Proteins in the blood can be used to gauge a person’s risk for cerebral small vessel disease, which affects millions of older adults.

Research brief: When tested in mice with melanoma tumors that were unlikely to stimulate an immune response, the approach increased the number of anti-tumor immune cells.

The funds will help the Simms/Mann–UCLA Center for Integrative Oncology expand its reach to community clinics.

UCLA researchers were part of an international team to test gene therapy in people with X-linked chronic granulomatous disease.

Rhinoplasty may make a woman appear to be three years younger, machine learning shows.

Dr. William “Billy” Cunningham, professor of medicine at the David Geffen School of Medicine at UCLA and health policy and management in the Fielding School of Public Health, died Jan. 2.

The longtime professor of health policy and management in the UCLA Fielding School of Public Health, died of cancer Jan. 5.

A UCLA-led study finds the practice effective and comparable to monitoring by physicians.

Devra and Jeff Schwartz expressed their gratitude to eight of the 100 strangers whose blood donations provided a lifeline for their 3-year-old son, Judah.

More than three-quarters of the adolescents in a family-focused treatment program recovered from their initial symptoms during the study.

Brookmeyer is an expert on how statistical tools can help address global public health challenges.

Scientists have been puzzled about why some people with heart failure live longer than others even after receiving the same treatment.

Research brief: There were no differences in outcomes for common surgical procedures between surgeons trained at foreign medical schools or the United States.

The researchers studied the mechanisms by which insulin may be secreted in the absence of glucose.

UCLA began observing its 100th birthday and delivered new advances in research, health care, the arts, community service and teaching.

Annual event at UCLA commemorates “the remarkable accomplishments of the last year and our patients’ incredible stories of hope and inspiration.”

Research brief: The findings also show that patient visits by Medicaid recipients to primary care physicians rose 3.6% during the first three years of the act.

The drug combination should be a first line of treatment, UCLA researchers say.

The advance could help scientists identify drugs to treat fibrosis, which plays a role in chronic kidney disease, liver cirrhosis and many other conditions.

UCLA researchers discovered differences in maternal and paternal X chromosomes that help explain sex differences in the immune system.

A combination approach could be new strategy for people with advanced cancers.

Scientists from 22 institutions, including UCLA, call for early diagnosis, prevention and treatment to reduce the risk of chronic diseases.

Degree program will help meet the rising demand for specialists trained to guide patients facing complex genetic disorders.

The UCLA-led team found that chronic opioid use increased the susceptibility to developing anxiety disorders.

Research brief: The new method, using robotics, will speed up how researchers test for therapies that block the metabolism of non-small-cell lung cancer tumors.